Data-Broadcasting Chip-on-a-Pill to Start Testing Within 18 Months
Pills that only contain medicine are so very 20th century. Swiss pharma house Novartis thinks pills needn't merely deliver medicine to the bloodstream, but could also monitor its effects and transmit data to physicians. As such, the firm plans to bring a chip-in-a-pill technology before European regulators within 18 months that can both deliver drugs and transmit information from inside a patient's body to a patch worn on the patient's skin. That patch in turn can transmit data to a smartphone or wireless network and on to the patient's doctor. The ingestible chips would be activated by stomach acid to notify doctors that patients are taking their medicines on schedule and at the proper dose--a particularly important aspect of recovery for organ transplant patients. As such, the technology will originally be packaged with one of Novartis's established transplant drugs that reduces the likelihood of organ rejection in patients. Related ArticlesChip in a...